Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 762064, 7 pages
http://dx.doi.org/10.1155/2013/762064
Clinical Study

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease

1Division of Medicine, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile
2Instituto de Bio-Oncología, Avenida Salvador 95, Oficina 95, Providencia, 7500710 Santiago, Chile
3Circulating Tumor Cell Unit, Faculty of Medicine, Universidad Mayor, Renato Sánchez 4369, Las Condes, 7550224 Santiago, Chile
4Faculty of Medicine, Universidad Diego Portales, Manuel Rodriguez Sur 415, 8370179 Santiago, Chile
5Urology Division, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile
6Foundation Arturo Lopez Perez, Rancagua 899, Providencia, 7500921 Santiago, Chile
7Division of Medicine, Hospital de Carabineros de Chile, Simón Bolívar 2200, Ñuñoa, 7770199 Santiago, Chile

Received 6 December 2012; Accepted 10 March 2013

Academic Editors: Volkan Tugcu and Murat Tunc

Copyright © 2013 Nigel P. Murray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • William C. Jackson, Benjamin Foster, Corey Foster, Darren Li, Skyler B. Johnson, Yeohan Song, Rohit Mehra, Howard Sandler, Jessica Zhou, Lakshmi Kunju, Felix Y. Feng, Daniel A. Hamstra, and Ganesh S. Palapattu, “Larger Maximum Tumor Diameter at Radical Prostatectomy Is Associated With Increased Biochemical Failure, Metastasis, and Death From Prostate Cancer After Salvage Radiation for Prostate Cancer,” International Journal Of Radiation Oncology Biology Physics, vol. 87, no. 2, pp. 275–281, 2013. View at Publisher · View at Google Scholar
  • Therese M. Becker, Nicole J. Caixeiro, Stephanie H. Lim, Annette Tognela, Norbert Kienzle, Kieran F. Scott, Kevin J. Spring, and Paul de Souza, “New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use,” International Journal of Cancer, vol. 134, no. 11, pp. 2523–2533, 2014. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Eduardo Reyes, Cynthia Fuentealba, Omar Jacob, and Nelson Orellana, “Extended use of P504S Positive Primary Circulating Prostate Cell Detection to Determine the Need for Initial Prostate Biopsy in a Prostate Cancer Scre,” Asian Pacific Journal Of Cancer Prevention, vol. 15, no. 21, pp. 9335–9339, 2014. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Eduardo Reyes, Cynthia Fuentealba, Nelson Orellana, and Omar Jacob, “Primary Circulating Prostate Cells Are Not Detected in Men with Low Grade Small Volume Prostate Cancer,” Journal of Oncology, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Lowes, Lock, Rodrigues, D'Souza, Bauman, Ahmad, Venkatesan, Allan, and Sexton, “The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy,” Prostate Cancer and Prostatic Diseases, vol. 18, no. 4, pp. 358–364, 2015. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Socrates Aedo, Eduardo Reyes, Nelson Orellana, Cynthia Fuentealba, and Omar Jacob, “Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells,” BJU International, vol. 118, no. 4, pp. 556–562, 2015. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Nelson Orellana, Cynthia Fuentealba, Eduardo Reyes, and Omar Jacob, “Comparison of the Walz nomogram and presence of secondary circulating prostate cells for predicting early biochemical failure after radical prostatectomy for prostate cancer in chilean men,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 16, pp. 7123–7127, 2015. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Socrates Aedo, Cynthia Fuentealba, Omar Jacob, Eduardo Reyes, Camilo Novoa, Sebastian Orellana, and Nelson Orellana, “Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2016. View at Publisher · View at Google Scholar
  • NigelP Murray, Eduardo Reyes, Nelson Orellana, Cynthia Fuentealba, and Omar Jacob, “Impact of age on the biochemical failure and androgen suppression after radical prostatectomy for prostate cancer in chilean men,” Cancer Translational Medicine, vol. 2, no. 4, pp. 105, 2016. View at Publisher · View at Google Scholar
  • Marketa Skerenova, Veronika Mikulova, Otakar Capoun, Tomas Zima, and Petra Tesarova, “Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression,” Biomedical Papers, 2017. View at Publisher · View at Google Scholar
  • Nigel P. Murray, Cynthia Fuentealba, Omar Jacob, Socrates Aedo, and Eduardo Reyes, “How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome,” Turkish Journal of Urology, vol. 43, no. 4, pp. 456–461, 2017. View at Publisher · View at Google Scholar
  • Lorenzo Tosco, Annouschka Laenen, Alberto Briganti, Paolo Gontero, R. Jeffrey Karnes, Patrick J. Bastian, Piotr Chlosta, Frank Claessens, Felix K. Chun, Wouter Everaerts, Christian Gratzke, Maarten Albersen, Markus Graefen, Burkhard Kneitz, Giansilvio Marchioro, Rafael Sanchez Salas, Bertrand Tombal, Thomas Van den Broeck, Henk Van Der Poel, Jochen Walz, Gert De Meerleer, Alberto Bossi, Karin Haustermans, Hendrik Van Poppel, Martin Spahn, and Steven Joniau, “The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis,” European Urology Focus, 2017. View at Publisher · View at Google Scholar
  • Nigel P. Murray, “Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management,” Biological Research, vol. 51, no. 1, 2018. View at Publisher · View at Google Scholar
  • Cynthia Fuentealba, Nigel P. Murray, Socrates Aedo, Eduardo Reyes, and Anibal Salazar, “Minimum residual disease in patients post radical prostatectomy for prostate cancer: Theoretical considerations, clinical implications and treatment outcome,” Asian Pacific Journal of Cancer Prevention, vol. 19, no. 1, pp. 229–236, 2018. View at Publisher · View at Google Scholar